These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 9659570)

  • 1. High-dose chemotherapy and autologous bone marrow or stem cell reconstitution for solid tumors.
    McGuire WP
    Curr Probl Cancer; 1998; 22(3):135-77. PubMed ID: 9659570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [High-dose chemotherapy with stem cell support for solid tumors in adults].
    Rodenhuis S; de Vries EG
    Ned Tijdschr Geneeskd; 1999 Apr; 143(14):731-8. PubMed ID: 10347628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of dose-intensified chemotherapy in the treatment of metastatic nonseminomatous testicular germ cell tumors. German Testicular Cancer Study Group.
    Bokemeyer C; Harstrick A; Beyer J; Metzner B; Rüther U; Hartmann JT; Holstein K; Derigs HG; de Wit R; Casper J; Schöffski P; Kührer I; Illiger HJ; Kempf B; Reichle A; Föller A; Hossfeld DK; Fischer JT; Berdel WE; Gerhartz HH; Kirchner H; Pflüger KH; Ostermann H; Kanz L; Schmoll HJ
    Semin Oncol; 1998 Apr; 25(2 Suppl 4):24-32; discussion 45-8. PubMed ID: 9578059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose chemotherapy for the treatment of breast and ovarian cancer.
    Cagnoni PJ; Shpall EJ
    Curr Opin Oncol; 1997 Mar; 9(2):122-5. PubMed ID: 9161788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [High-dose chemotherapy and autologous bone marrow transplantation in solid tumors. A review].
    Handberg J; Hansen SW
    Ugeskr Laeger; 1996 Jul; 158(29):4175-80. PubMed ID: 8701532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with early poor prognosis breast cancer.
    Farquhar C; Basser R; Marjoribanks J; Lethaby A
    Cochrane Database Syst Rev; 2003; (1):CD003139. PubMed ID: 12535457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with metastatic breast cancer.
    Farquhar C; Basser R; Hetrick S; Lethaby A; Marjoribanks J
    Cochrane Database Syst Rev; 2003; (1):CD003142. PubMed ID: 12535458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of failure of complete responders following high-dose chemotherapy and autologous bone marrow transplantation for metastatic breast cancer: implications for the use of adjuvant radiation therapy.
    Mundt AJ; Sibley GS; Williams S; Rubin SJ; Heimann R; Halpern H; Weichselbaum RR
    Int J Radiat Oncol Biol Phys; 1994 Aug; 30(1):151-60. PubMed ID: 8083108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation for metastatic breast cancer.
    Rowlings PA; Williams SF; Antman KH; Fields KK; Fay JW; Reed E; Pelz CJ; Klein JP; Sobocinski KA; Kennedy MJ; Freytes CO; McCarthy PL; Herzig RH; Stadtmauer EA; Lazarus HM; Pecora AL; Bitran JD; Wolff SN; Gale RP; Armitage JO; Vaughan WP; Spitzer G; Horowitz MM
    JAMA; 1999 Oct; 282(14):1335-43. PubMed ID: 10527180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A systematic overview of chemotherapy effects in acute myeloid leukaemia.
    Kimby E; Nygren P; Glimelius B;
    Acta Oncol; 2001; 40(2-3):231-52. PubMed ID: 11441935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose chemotherapy and autologous stem-cell transplantation for ovarian cancer: an autologous blood and marrow transplant registry report.
    Stiff PJ; Veum-Stone J; Lazarus HM; Ayash L; Edwards JR; Keating A; Klein JP; Oblon DJ; Shea TC; Thomé S; Horowitz MM
    Ann Intern Med; 2000 Oct; 133(7):504-15. PubMed ID: 11015163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with metastatic breast cancer.
    Farquhar C; Marjoribanks J; Basser R; Hetrick S; Lethaby A
    Cochrane Database Syst Rev; 2005 Jul; 2005(3):CD003142. PubMed ID: 16034887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of high-dose chemotherapy in the treatment of multiple myeloma: a controversy.
    Kyle RA
    Ann Oncol; 2000; 11 Suppl 1():55-8. PubMed ID: 10707780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer. Philadelphia Bone Marrow Transplant Group.
    Stadtmauer EA; O'Neill A; Goldstein LJ; Crilley PA; Mangan KF; Ingle JN; Brodsky I; Martino S; Lazarus HM; Erban JK; Sickles C; Glick JH
    N Engl J Med; 2000 Apr; 342(15):1069-76. PubMed ID: 10760307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with early poor prognosis breast cancer.
    Farquhar C; Marjoribanks J; Basser R; Lethaby A
    Cochrane Database Syst Rev; 2005 Jul; (3):CD003139. PubMed ID: 16034886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose therapy and autologous stem-cell transplantation versus conventional-dose consolidation/maintenance therapy as postremission therapy for adult patients with lymphoblastic lymphoma: results of a randomized trial of the European Group for Blood and Marrow Transplantation and the United Kingdom Lymphoma Group.
    Sweetenham JW; Santini G; Qian W; Guelfi M; Schmitz N; Simnett S; Nagler A; Holte H; Kvaloy S; Bruzzi P; Goldstone AH
    J Clin Oncol; 2001 Jun; 19(11):2927-36. PubMed ID: 11387366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose chemotherapy and peripheral blood progenitor cell transplantation in the treatment of breast cancer.
    Peters WP; Dansey RD; Klein JL; Baynes RD
    Oncologist; 2000; 5(1):1-13. PubMed ID: 10706643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A feasibility study of multiple cycle therapy with melphalan, thiotepa, and paclitaxel followed by mitoxantrone, thiotepa, and paclitaxel with autologous hematopoietic cell support for metastatic breast cancer.
    Hu WW; Long GD; Stockerl-Goldstein KE; Johnston LJ; Chao NJ; Negrin RS; Blume KG
    Clin Cancer Res; 1999 Nov; 5(11):3411-8. PubMed ID: 10589752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [High-dose therapy and hematopoietic cell autotransplantation in the treatment of adult gynecologic tumors].
    Lotz JP; Pene F; Bouleuc C; André T; Gligorov J; Avenin D; Esteso A; Bellaiche A; Macovei C; Merad Z; Laadem A; Vanica R; Izrael V
    Contracept Fertil Sex; 1996 Apr; 24(4):307-18. PubMed ID: 8704806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of G-CSF or GM-CSF mobilized peripheral blood progenitor cells (PBPC) alone or to augment marrow as hematologic support of single or multiple cycle high-dose chemotherapy.
    Elias AD; Ayash L; Tepler I; Wheeler C; Schwartz G; Mazanet R; Schnipper L; Frei E; Antman K
    J Hematother; 1993; 2(3):377-82. PubMed ID: 7522891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.